Sg3 Management, LLC Theravance Biopharma, Inc. Call Options Transaction History

Sg3 Management, LLC

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2022 Aug 15, 2022	SELL	$8.41 - $10.34 $294,350 - $361,900	-35,000 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$8.33 - $12.96 $291,550 - $453,600	35,000 New	35,000 $335,000
Q4 2021 Feb 15, 2022	SELL	$7.42 - $11.05 $103,880 - $154,700	-14,000 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$6.77 - $14.41 $94,780 - $201,740	14,000 New	14,000 $104,000

122

47.3M

200

12.8K

Ticker TBPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,782,400
Market Cap $658M
Description
Theravance Biopharma, Inc., a biopharmaceutical company, discovers, develops, and commercializes respiratory medicines in the United States, Europe, and Asia. The company offers YUPELRI, a once-daily, nebulized long-acting muscarinic antagonist used for the treatment of chronic obstructive pulmonary disease (COPD). Its product portfolio also inc...

Get notified when there are updates to the investment portfolio of Sg3 Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sg3 Management, LLC with notifications on news.